Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOOD-WP3 cognitive outcomes in older adults with type 2 diabetes
2017-004663-12Phase 4Terminated
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Trajenta plus metformin with Novonorm plus metformin (2 arms). Primary endpoints: Incidence of major comorbidities, Physical performance (SPPB) and 2 more. Started May 2021; status: terminated.
02
Drugs
linagliptinrepaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-004663-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004663-12.